Hormone replacement therapy (HRT) has become a vital topic for many women navigating the challenging transition of perimenopause. Amy Schumer, who discovered she was in perimenopause, turned to HRT ...
1h
News-Medical.Net on MSNUS Patent Office grants Closed Loop Medicine key patents for cardiometabolic capabilities in GLP-1 and Direct Oral Anti-Coagulants (DOAC) therapiesClosed Loop Medicine Ltd., a leader in AI-enabled precision medicines, today announced the expansion of its US patent portfolio. Strengthening its cardiometabolic treatment portfolio, the Company now ...
Hims & Hers has risen since November 2024, outperforming the S&P 500. Click here to see why HIMS stock is a Buy.
Spending on GLP-1 drugs continues to rise, after outpacing trends among specialty drugs for the first time in 2023, according ...
Patients with diabetes or obesity receiving GLP-1 RAs are unlikely to experience an increase in the already low rates of ...
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...
It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
I’m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’m wondering about Ozempic.
13h
Discover Magazine on MSNNew Drug Delivery System Could Reduce GLP-1 Shortage and Make It More EfficientLearn how chemists have invented a new technology to solve the shortage of GLP-1 medications by improving drug delivery.
With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...
However, one industry observer cautions against moving forward with specific GLP-1 claims on packaging until federal agencies ...
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results